+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 20Years - 40Years
FEMALE
ID07861399

Comparing Dual Trigger and hCG Trigger for Final Oocyte Maturation in Normal Responders Undergoing ICSI

Led by Al-Azhar University · Updated on 2026-10-06

100

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing the effects of a dual trigger versus a conventional hCG trigger for final oocyte maturation in women who respond normally to ovarian stimulation during ICSI cycles. The study aims to evaluate embryological and reproductive outcomes to better understand which method may influence the number of mature eggs and pregnancy rates. Participants are divided into two groups one receives a combination of a GnRH agonist with hCG dual trigger, and the other receives hCG alone standard trigger. Both interventions are given in the context of ICSI treatment cycles following a GnRH antagonist protocol. The study monitors outcomes such as the number of mature oocytes, fertilization rates, embryo quality, implantation rates, pregnancy outcomes, and the incidence of ovarian hyperstimulation syndrome. During the study, participants undergo oocyte retrieval and assessment shortly afterward. Researchers measure maturation status, fertilization success approximately 16-18 hours post-insemination, embryo development by days 3-5, and clinical pregnancy rates at 5-7 weeks after embryo transfer. Safety monitoring includes tracking ovarian hyperstimulation syndrome from trigger until two weeks after retrieval. The entire study runs from initial treatment until pregnancy evaluation, with participant age limited to 20 to 40 years.

CONDITIONS

Brief Title

Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders

Research Team

A

Ahmed MM Gebreel, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here